Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Ebel, US
Brian Ebel, Towson, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20100212189 | Foot pad for relieving pain - A foot pad for relieving pain while engaging in weight bearing activity is provided. A pad can include an arch portion fitting under and adjacent to the medial longitudinal arch of the foot, offsetting the soft tissue of the medial longitudinal arch thereby supporting the calcaneo-navicular ligament structure, wherein the arch portion extends from front to rear, of the longitudinal medial arch, and the arch portion extends from the medial side towards the lateral side, of the longitudinal medial arch. Furthermore, the pad can provide a heel portion of the pad fitting under the heel of the foot, the heel portion connecting a medial side portion of the pad to a lateral side portion of the pad, cushioning and reduces soreness and pressure from the sole of the foot by offsetting the soft tissue of the medial longitudinal arch, thereby supporting the calcaneo-navicular ligament structure reducing over-pronation and increasing supination of the foot during weight bearing activity, offsetting and cushioning the soft tissue of the outer portions of sole of the heel and offsetting the central portion of the heel from the surface immediately below the pad at a distance of approximately the thickness of the pad, during weight bearing activity. | 08-26-2010 |
Christopher Ebel, Manassas, VA US
| Patent application number | Description | Published |
|---|---|---|
| 20100276794 | SYSTEM AND METHOD FOR MULTI-CHIP MODULE DIE EXTRACTION AND REPLACEMENT - A system and method are provided in which a first chip in a stacked multi-chip module configuration is affixed via one or more adhesion layers to a first portion of a partitioned interposer unit. Planar partitions of the interposer are physically bonded via multiple solder “bumps,” which possess high tensile strength but low resistance to horizontal shear force or torque. A second chip is affixed via one or more adhesion layers to the second portion of the partitioned interposer. The chips may thus be separated by horizontally and oppositely shearing or twisting the first and second portions of the partitioned interposer away from one another. | 11-04-2010 |
Edward Ebel, Chesterfield, VA US
| Patent application number | Description | Published |
|---|---|---|
| 20110040608 | Methods and Systems for an Improved Rewards Program - Systems and methods encourage customer loyalty by providing an enhanced rewards program. A customer with an account with an account provider may receive a reward (e.g., cash back) for activity with respect to the account. To encourage loyalty, the customer may be asked whether they wish to save the reward, and the saved reward may be enhanced based at least in part on subsequent activity with respect to the account (e.g., maintaining the account in good standing for a predetermined time). The customer may be awarded the enhanced reward once the conditions of the subsequent activity have been satisfied. In one example embodiment, a customer may receive cash back as a reward for a purchase. As an incentive to remain with the financial institution, the customer may decline to redeem the cash back, and the cash back amount may increase by a multiple after a predetermined time. | 02-17-2011 |
James A. Ebel, Jacksonville, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20110085937 | Method and Apparatus of Sterilization Using Monochromatic UV Radiation Source - This invention provides a process of sterilizing a medical device, and preferably the contents of a sealed container which comprises said medical device, comprising the step of exposing said medical device to monochromatic ultraviolet radiation whereby the D | 04-14-2011 |
James Patrick Ebel, Lebanon, OH US
| Patent application number | Description | Published |
|---|---|---|
| 20080241226 | Methods and Kits For Administering Probiotics - Methods for administering probiotics comprising the steps of: administering a loading dose of a loading probiotic for a loading time period; and administering a dose of a botanical and/or additional materials for the loading time period are disclosed. The methods also include administering a maintenance dose of a maintenance probiotic, and/or a botanical and/or an additional material for a maintenance time period. Also disclosed are kits for use in administering probiotics. | 10-02-2008 |
| 20080262072 | Compositions And Kits Comprising A Melatonin Component And A Flavanol Component - Disclosed herein are compositions and kits, wherein each composition comprises a melatonin component, a flavanol component, or both, and wherein each kit comprises a melatonin component and a flavanol component. The compositions and kits are useful for restorative sleep function and enhanced energy. Further disclosed herein are methods of using the compositions and kits. | 10-23-2008 |
| 20090196921 | Compositions Methods and Kits For Enhancing Immune Response To A Respiratory Condition - Disclosed herein are compositions for treating a respiratory condition, preferably by enhancing immune response in a mammal, the compositions including a therapeutic amount of a probiotic strain of bacteria and a therapeutic amount of an additional component. Also included are methods of treating a respiratory condition, preferably by enhancing immune response, in a mammal. Kits containing the compositions, and instructions for applying the methods are also included. The method includes orally administering to the mammal a therapeutic amount of a probiotic strain of bacteria and a therapeutic amount of an additional component. | 08-06-2009 |
Mark Ebel, Denville, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20110125593 | ONLINE MARKETING PAYMENT MONITORING METHOD AND SYSTEM - A method of collecting and correlating information about user interactions with a plurality of websites including adding a first cookie from a first website, the first cookie recording information concerning interactions of a user with the first website; adding a second cookie from a second website, the second cookie recording information concerning interactions of the user with the second website; initiating a tracking pixel on a third website; capturing information from the first and second cookie; and determining a first contribution of the first website and a second contribution of the second website to interests in the third website. | 05-26-2011 |
Michael John Ebel, Brighton, MI US
| Patent application number | Description | Published |
|---|---|---|
| 20100156162 | SEAT BACK ASSEMBLY WITH INTEGRAL REINFORCEMENT STRUCTURE - A seat back assembly including a frame formed of a low density material such as expanded polypropylene (EPP) and a reinforcement structure encapsulated within the frame is provided. The reinforcement structure includes a load transferring surface extending between opposite ends of the seat back. Each end of the reinforcement structure is secured to a vehicle body structure. The reinforcement structure transfers a load placed upon the seat back assembly throughout the frame so as to maintain the structural integrity of the frame under a predetermined load. Specifically, the load transferring surface of the reinforcement structure is in contact with the frame and transfers the load across a predetermined area of the frame and to the vehicle body. | 06-24-2010 |
Wolfgang Ebel, Philadelphia, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20080292641 | Antigenic GM-CSF peptides and antibodies to GM-CSF - Hybridoma lines that secrete human monoclonal antibodies with high binding specificity and biological activity, particularly neutralizing activity against granulocyte-macrophage colony stimulating factor, and methods of generating the hybridoma lines are provided. Target antigens and epitopes are also provided. The antibodies may be used in therapeutic methods, for example in the treatment of cancer, infectious disease, or autoimmune disease. | 11-27-2008 |
| 20090202559 | Anti-Mesothelin Antibodies - This invention relates to the use of monoclonal and polyclonal antibodies that specifically bind to and become internalized by mesothelin-positive cells and also induce an immune effector activity such as antibody dependent cellular cytotoxicity. The antibodies are useful in specific delivery of pharmacologic agents to mesothelin expressing cells as well as eliciting an immune-effector activity particularly on tumor cells and precursors. The invention is also related to cells expressing the monoclonal antibodies, polyclonal antibodies, antibody derivatives, such as human, humanized, and chimeric monoclonal antibodies, antibody fragments, mammalian cells expressing the monoclonal antibodies, derivatives and fragments, and methods of treating cancer using the antibodies, derivatives and fragments. | 08-13-2009 |
| 20100028336 | Anti-Mesothelin Antibodies - This invention relates to the use of monoclonal and polyclonal antibodies that specifically bind to and become internalized by mesothelin-positive cells and also induce an immune effector activity such as antibody dependent cellular cytotoxicity. The antibodies are useful in specific delivery of pharmacologic agents to mesothelin expressing cells as well as eliciting an immune-effector activity particularly on tumor cells and precursors. The invention is also related to cells expressing the monoclonal antibodies, polyclonal antibodies, antibody derivatives, such as human, humanized, and chimeric monoclonal antibodies, antibody fragments, mammalian cells expressing the monoclonal antibodies, derivatives and fragments, and methods of treating cancer using the antibodies, derivatives and fragments. | 02-04-2010 |
| 20100272730 | Antigenic GM-CSF Peptides And Antibodies To GM-CSF - Hybridoma lines that secrete human monoclonal antibodies with high binding specificity and biological activity, particularly neutralizing activity against granulocyte-macrophage colony stimulating factor, and methods of generating the hybridoma lines are provided. Target antigens and epitopes are also provided. The antibodies may be used in therapeutic methods, for example in the treatment of cancer, infectious disease, or autoimmune disease. | 10-28-2010 |
Wolfgang Ebel, Plymouth Meeting, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100008851 | ANTI-GD2 ANTIBODIES AND METHODS AND USES RELATED THERETO - Described herein are antibodies that specifically bind ganglioside GD2. Also described are nucleotides encoding such antibodies, cells expressing such antibodies, methods of use for such antibodies, and methods for using the antibodies to treat diseases associated with ganglioside GD2. In addition, tissue culture media supplements are described as are methods of use for the supplements. Described herein are albumin-ganglioside conjugates and corresponding methods for producing such conjugates. Methods of purifying or isolating antibodies are also described. | 01-14-2010 |